Nerandomilast, a PDE4 inhibitor, has shown significant efficacy in progressive pulmonary fibrosis (PPF), offering an ...
A new study reports that a routine, low-cost nutritional assessment tool may offer a powerful way to predict survival in patients with progressive pulmonary fibrosis (PPF), a life-shortening condition ...
Researching IPF after her late husband's diagnosis meant learning many new acronyms and abbreviations, says guest writer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback